Source: Annual Congress 2002 - Aspects of respiratory disease in primary care
Disease area: Airway diseases

Abstract

Introduction. After a series of educational campaigns carried on in Romania in a period of 2 years in the field of COPD, we tried to unravel the therapeutic attitude for a patient suffering of such a disease. Material and method. Questionnaires with 41 questions were sent to 101 pneumologists. Most of them were MD (65,3%), with an average age of 42 ±] 8,8 years, most of them being in the urban milieu – 92,1%. Results and discussions. The physicians have in evidence an average 66,5 ±] 77 patients with COPD; they are controlled an a average at 9,6 ±] 6 weeks, and after being hospitalized at 5,7 ±] 5,5 weeks. On a average, they know a single consensus (44,6% only the Romanian consensus) and only 44,6% took part in a courses of improvement in this field. From the therapeutic point of view they use in 59,4% cases anticolinergics in the first line, in 53,5% in second line β2 mimetics and in 32,7% in the third line the xantines. Nevertheless, 87% use myofilin injectible, 91% hemisucinat of hydrocortisone in the case of exacerbation. For a better control of this disease, only 26,7% consider important the anti-tobacco measures and 71,3% feel the absence of scientific educational material for the physicians; 54% need a spirometer, for improving the investigation of this disease Conclusions. The study reveals that in Romania still exists serious deficiencies concerning the pneumologists education and the absence of a minimum endowments of the consulting rooms and hospitals. It requires to be worked out some educational material for patients and medical staff dealing with such problems. Study sponsored by Boehringer Ingelheim Pharmaceutical Company – Romanian branch.

Rating:

Share or cite this content

Citations should be made in the following way:
F. D. Mihaltan, R. Ulmeanu, G. Paun, M. Ioanas (Bucharest, Romania). Therapeutic approaches in the chronic obstructive (COPD) pulmonary disease. Eur Respir J 2002; 20: Suppl. 38, 2980

Member's Comments

No comment yet.

Related content which might interest you: Optimal assessment and management of chronic obstructive pulmonary disease (COPD) Source: Guideline 1995 Year: 1995 Chronic obstructive pulmonary disease (COPD) – patient‘s perspective Source: Eur Respir J 2007; 30: Suppl. 51, 168s Year: 2007 Potential biomarkers in patients with chronic obstructive pulmonary disease (COPD) Source: Virtual Congress 2020 – Mechanistic insight into lung injury and repair Year: 2020 Enalapril in the management of patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2003; 22: Suppl. 45, 241s Year: 2003 The impact of using different symptom-based exacerbation algorithms in patients with COPD Source: Eur Respir J 2011; 37: 1260-1268 Year: 2011 Therapeutic responses in asthma and chronic obstructive pulmonary disease Source: Annual Congress 2008 - PG17 - An expert view of the differences between asthma and COPD Year: 2008 Correlates of osteoporosis in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities Year: 2010 Cilomilast is efficacious in chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2003; 22: Suppl. 45, 68s Year: 2003 Accelerated ageing and chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2003 - Cigarette smoke: how it does its dirty work Year: 2003 Pathogenic therapy of patients with chronic obstructive pulmonary diseases (COPD) Source: Annual Congress 2007 - New insights into the treatment of COPD Year: 2007 The evaluation of a helpline for chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2004 - Smoking and cessation in respiratory disease Year: 2004 The state of patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2007; 30: Suppl. 51, 547s Year: 2007 Periodontitis and chronic obstructive pulmonary disease Source: Annual Congress 2006 - COPD and inflammation Year: 2006 Acute effects of sildenafil in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - Pulmonary hypertension I Year: 2008 Use of telehealth in the management of patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2010 - COPD: treatment and monitoring Year: 2010 Prognosis after non-invasive ventiltation (NIV) for chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2011 - Recent advances in noninvasive ventilation used for treating acute respiratory failure Year: 2011 Awareness of chronic obstructive pulmonary disease (COPD) in Portugal Source: Eur Respir J 2007; 30: Suppl. 51, 126s Year: 2007 Model of staged development chronic obstructive pulmonary disease (COPD) in rats Source: Annual Congress 2011 - Novel mechanisms in lung injury Year: 2011 Influence of bronchodilators on pulmonary hypertension in patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2003; 22: Suppl. 45, 427s Year: 2003 Chronic obstructive pulmonary disease (COPD) patients with bronchiectasis: clinical features? Source: International Congress 2018 – COPD exacerbations and bronchiectasis Year: 2018